| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/25/2013 | CN103316077A Drug composition for sterilization and itching-relieving |
| 09/25/2013 | CN103316064A Liquid medicine for treating scalds and preparation method thereof |
| 09/25/2013 | CN103316051A New functions and applications of trametes lactinea(Berk.)Pat. or extractives and trametenloic acid B |
| 09/25/2013 | CN103316049A Anti-allergic rhinitis combination drug |
| 09/25/2013 | CN103316040A Rehydration method of piglet diarrhea rehydration salts |
| 09/25/2013 | CN103316038A Pyruvate oral rehydration salt composition for curing circulation hypovolemia or water-losing with salt-losing |
| 09/25/2013 | CN103316033A Gel and use thereof |
| 09/25/2013 | CN103316032A A hydroxytyrosol composition and applications thereof |
| 09/25/2013 | CN103316031A Weight reduction and body fat reduction applications of chitosan oligosaccharide |
| 09/25/2013 | CN103316030A Medicament for treating nasal obstruction when catching a cold |
| 09/25/2013 | CN103316029A Application of Polyflavanostilbene A in preparation of medicine for treating Alzheimer disease |
| 09/25/2013 | CN103316028A Application of Polyflavanostilbene A in preparation of drug for treating or preventing chronic heart failure |
| 09/25/2013 | CN103316027A Application of catalpol and retinoic acid medicine composition in preparing medicine used for preventing or treating white matter damage |
| 09/25/2013 | CN103316026A Combined product containing phentermine and topiramate, and preparation method thereof |
| 09/25/2013 | CN103316025A Application of p-hydroxyl acetophenone glycosidase to medicine for autoimmunity disease and transplant rejection disease |
| 09/25/2013 | CN103316024A Application of labdane diterpene glycoside compounds in rubus chingii Hu as medicine |
| 09/25/2013 | CN103316023A Novel lotion for females |
| 09/25/2013 | CN103316022A Pharmaceutical composition composed of aspirin and vitamin C and used for preventing and treating lung injury caused by smoking |
| 09/25/2013 | CN103316021A Medicine composition composed of calcitriol and calcium-containing substances and applications |
| 09/25/2013 | CN103316020A Applications of demethoxyviridin in preparing Amyloid-beta aggregation inhibitor |
| 09/25/2013 | CN103316019A Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression |
| 09/25/2013 | CN103316018A Applications of latanoprost in preparation of medications for treating diabetes and/or hypertriglyceridemia and complications thereof |
| 09/25/2013 | CN103316017A Bis(alpha-furancarboxylato)oxovanadium composition for treatment of diabetes |
| 09/25/2013 | CN103316016A Pharmaceutical composition containing carbamazepine and application thereof |
| 09/25/2013 | CN103316015A Medicine for treating epistaxis through oral administration and external use and method thereof |
| 09/25/2013 | CN103316014A Specific acupuncture function composite material, preparation method thereof and applications |
| 09/25/2013 | CN103316013A Aprepitant composition for injection |
| 09/25/2013 | CN103316012A Application of Aspeverin in preparation of medicine for treating pancreas cancer |
| 09/25/2013 | CN103316011A Application of Aspeverin in preparation of medicine for treating skin cancer |
| 09/25/2013 | CN103316010A Application of Aspeverin in preparation of medicine for treating liver cancer |
| 09/25/2013 | CN103316009A Application of Aspeverin in preparation of medicine for treating cervical carcinoma |
| 09/25/2013 | CN103316008A Application of Aspeverin in preparation of medicine for treating rectal cancer |
| 09/25/2013 | CN103316007A Application of Myriberine A in preparation of anti-hypoxic drug |
| 09/25/2013 | CN103316006A Application of Myriberine A in preparation of medicine for treating lung cancer |
| 09/25/2013 | CN103316005A Praziquantel-mebendazole nanoemulsion oral liquid and preparation method thereof |
| 09/25/2013 | CN103316004A Pharmaceutical composition used for preventing and controlling metabolic syndrome and application thereof |
| 09/25/2013 | CN103316003A Sarafloxacin hydrochloride clathrate and preparation method thereof |
| 09/25/2013 | CN103316002A Application of compound in preparation of drug for treating breast cancer |
| 09/25/2013 | CN103316001A Omeprazole sodium composition for injection |
| 09/25/2013 | CN103316000A Heterocyclic amides as ROCK inhibitors |
| 09/25/2013 | CN103315999A Compound amino acid composition and preparation method thereof |
| 09/25/2013 | CN103315998A Pharmaceutical composition containing 18 kinds of amino acids |
| 09/25/2013 | CN103315997A Pharmaceutical composition containing 18 kinds of amino acids |
| 09/25/2013 | CN103315996A Pharmaceutical composition used for preventing and controlling atherosclerosis and application thereof |
| 09/25/2013 | CN103315995A Use of alpha-hydroxy carbonyl compounds as reducing agents |
| 09/25/2013 | CN103315994A Application of Aphanamgrandiol A in preparation of medicine used for preventing or treating oral ulcer |
| 09/25/2013 | CN103315993A Application of dihydromyricetin in preparation of medicines for inhibiting adriamycin cardiotoxicity |
| 09/25/2013 | CN103315992A Liquiritigenin oral preparation, injection preparation and preparation method thereof |
| 09/25/2013 | CN103315991A Application of Nardoaristolones A in preparation of medicine resistant to tubercle bacillus |
| 09/25/2013 | CN103315990A Application of Nardoaristolones A in preparation of medicine used for inhibiting proliferation of fibroblast of liver |
| 09/25/2013 | CN103315989A Pharmaceutical composition |
| 09/25/2013 | CN103315988A New application of N-acetylcysteine medicine |
| 09/25/2013 | CN103315987A Pharmaceutical composition for treating epilepsy |
| 09/25/2013 | CN103315986A A soluble and stable ponazuril composition and a preparation method thereof |
| 09/25/2013 | CN103315985A Application of Fingolimod in preparing medicine for inhibiting liver cancer intrahepatic metastasis |
| 09/25/2013 | CN103315984A Applications of Fingolimod in preparation of drugs for inhibiting IL-6 secretion of hepatoma cells, |
| 09/25/2013 | CN103315983A Rasagiline preparation and preparation method thereof |
| 09/25/2013 | CN103315982A Usage of magnolol as CYP2E1 enzyme inhibitor |
| 09/25/2013 | CN103315981A Application of biphenol and/or derivatives thereof in preparation of drugs for inhibiting cancer cell metastasis |
| 09/25/2013 | CN103315979A Lappaconitine sustained release preparation composition and preparation method thereof |
| 09/25/2013 | CN103315978A Dry docetaxel elixir, and preparation method and application thereof |
| 09/25/2013 | CN103315977A Folic acid modified quercetin lipid nano-capsule preparation and preparation method thereof |
| 09/25/2013 | CN103315974A Osmotic pump type controlled release preparation containing donepezil and its salt and preparation method thereof |
| 09/25/2013 | CN103315973A Quetiapine osmotic pump controlled release preparation |
| 09/25/2013 | CN103315972A Moxifloxacin hydrochloride tablets and preparation method thereof |
| 09/25/2013 | CN103315971A Acarbose tablets and preparation method thereof |
| 09/25/2013 | CN103315970A Ranitidine hydrochloride powder injection for injection |
| 09/25/2013 | CN103315968A Powder injection for injection and preparation method thereof |
| 09/25/2013 | CN103315967A Nedaplatin-containing freeze-drying composition as well as application and preparation method thereof |
| 09/25/2013 | CN103315965A Oral solid granule suitable for infants and children, and preparation method thereof |
| 09/25/2013 | CN103315964A Method for preparing sweet clarithromycin granules |
| 09/25/2013 | CN103315963A Stable lamivudine granule |
| 09/25/2013 | CN103315962A Tamsulosin sustained-release pellet preparation and preparation method thereof |
| 09/25/2013 | CN103315961A Neogambogic acid self-microemulsifying preparation and preparation method thereof |
| 09/25/2013 | CN103315959A Orally taken colon-targeted preparation for treatment of inflammatory bowel diseases and preparation method thereof |
| 09/25/2013 | CN103315958A 2-(1-methylethyl)-5-[(E)-2-phenylethenyl]benzene-1,3-diol nanoemulsion and its preparation method |
| 09/25/2013 | CN103315957A Vitamin K1 lyophilized oral emulsion and preparation method thereof |
| 09/25/2013 | CN103315955A Sarafloxacin hydrochloride sustain-released injection and preparation method thereof |
| 09/25/2013 | CN103315954A Compositions and methods for making and using nanoemulsions |
| 09/25/2013 | CN103315953A Fenofibrate self-microemulsifying preparation and preparation method thereof |
| 09/25/2013 | CN103315952A Microemulsion carrier system for poorly water-soluble drugs and preparation method and uses thereof |
| 09/25/2013 | CN103315951A Low-molecular-weight heparin calcium injection |
| 09/25/2013 | CN103315950A Multi-layer co-extruded membrane packed flucytosine injection for transfusion and preparation method thereof |
| 09/25/2013 | CN103315948A Nimodipine polymer blending micelle preparation and preparation method thereof |
| 09/25/2013 | CN103315947A Tigecycline composition for injection |
| 09/25/2013 | CN103315907A Resin container filled with antifungal pharmaceutical composition |
| 09/25/2013 | CN103315205A Use of non-digestable sacharides for giving an infant the best start after birth |
| 09/25/2013 | CN103315106A Making method of bagged tea for reducing blood pressure and blood fat |
| 09/25/2013 | CN103314925A Method for preparing rhesus monkey type 2 diabetic model |
| 09/25/2013 | CN102920702B Dihydroartemisinin and Chinese blister beetle composition, enteric preparation and application and preparation thereof |
| 09/25/2013 | CN102885900B Composite with weight loss function and preparation method of composite |
| 09/25/2013 | CN102871967B Preparation of salified medicinal particles of levosalbutamol and traditional Chinese medicine monomer and preparation of particle inhalable aerosol |
| 09/25/2013 | CN102824309B Cefmetazole sodium powder for injection and preparation method thereof |
| 09/25/2013 | CN102784395B Application of MAPK-ERK1/2 signal channel inhibitor to preparation of double-minute medicine for removing or inhibiting tumor cells |
| 09/25/2013 | CN102764258B Preparation method of candesartan cilexetil amlodipine compound tablet |
| 09/25/2013 | CN102764257B Flupirtine maleate sustained release tablet |
| 09/25/2013 | CN102755348B Carbohydrate and electrolyte injection and preparation method thereof |
| 09/25/2013 | CN102755299B Preparation process of pralidoxime chloride powder injection for injection |
| 09/25/2013 | CN102727522B Compound double-release capsule preparation composed of bromodihydroartemisinin and Fe<2+> agent |
| 09/25/2013 | CN102727439B Tigecycline liposome injection |